-
'Better to go to prison': Israeli ultra-Orthodox rally against army service
-
Bublik downs fourth seed Fritz to reach Paris Masters quarters
-
UN climate fund posts record year as chief defends loans
-
Man Utd must ignore outside noise to go in 'right direction', says Wilcox
-
G7 to launch 'alliance' countering China's critical mineral dominance
-
Wallaby boss Schmidt wary of Ford's 'triple threat'
-
Swedish hate-crime trial shines light on far-right 'fitness clubs'
-
Trump call for nuclear tests sows confusion
-
Chinese EV giant BYD says Q3 profit down 33%
-
ECB holds rates steady with eurozone more resilient
-
Independent Macau media outlet says it will close by December
-
Shares in Jeep-maker Stellantis slump despite rising sales
-
Shelton beats Rublev to reach Paris Masters last eight
-
Trump stirs tensions with surprise order to test nuclear weapons
-
S.Africa court rules ANC leader Luthuli was killed in apartheid 'assault'
-
Stocks slide as investors digest Trump-Xi talks, earnings
-
No GDP data released as US shutdown bites
-
PSG's injured Doue to miss Bayern match, out for several weeks
-
Litchfield ton guides Australia to 338 in World Cup semis
-
S.Africa court rules ANC leader Luthuli killed in apartheid 'assault'
-
With inflation under control, ECB holds rates steady again
-
Nigerian designer embraces 'clashes' and 'chaos' at Lagos Fashion Week
-
Nissan says expects $1.8 bn operational loss in 2025-26
-
Italy court stalls Sicily bridge, triggers PM fury
-
Marseille midfielder Nadir stable after on-pitch collapse
-
Saudis turned down Messi stint ahead of 2026 World Cup, says official
-
Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera
-
Universal says struck first licensing deal for AI music
-
France arrests five new suspects over Louvre heist: prosecutor
-
Record Vietnam floods kill 10, turn streets into canals
-
Trump orders US to start nuclear weapons testing
-
'Significant' Xi, Trump talks win cautious optimism in China
-
French justice minister visits jailed former president Sarkozy
-
Eurozone growth beats expectations in third quarter
-
Bali trial begins for 3 accused of Australian's murder
-
Dutch election a photo finish between far-right, centrists
-
IOC removes Saudi Arabia as host of inaugural Esports Olympics
-
Russia batters Ukraine energy sites, killing two
-
Shell's net profit jumps despite lower oil prices
-
Pakistani security source says Afghanistan talks 'likely' to resume
-
Fentanyl, beans and Ukraine: takeaways from Trump-Xi's 'great meeting'
-
Branson's Virgin moves closer to launching Eurostar rival
-
Russia hits Ukraine energy sites, killing one, wounding children
-
Asia markets fluctuate as investors mull Trump-Xi talks
-
Trump, Xi ease fight on tariffs, rare earths
-
Volkswagen posts 1-billion-euro loss on tariffs, Porsche woes
-
'Fight fire with fire': California mulls skewing electoral map
-
Fentanyl, beans and Ukraine: Trump hails 'success' in talks with Xi
-
'Nowhere to sleep': Melissa upends life for Jamaicans
-
Irish octogenarian enjoys new lease on life making harps
| RBGPF | 0% | 79 | $ | |
| RYCEF | 0.32% | 15.45 | $ | |
| CMSC | -0.48% | 24.125 | $ | |
| RIO | -0.7% | 72.076 | $ | |
| AZN | 0.29% | 82.47 | $ | |
| VOD | 0.38% | 11.945 | $ | |
| BTI | -0.73% | 51.345 | $ | |
| RELX | -0.56% | 44.44 | $ | |
| NGG | 0.53% | 75.95 | $ | |
| GSK | 2.17% | 46.95 | $ | |
| BCC | -0.14% | 70.23 | $ | |
| SCS | 0.72% | 16.075 | $ | |
| CMSD | -0.12% | 24.53 | $ | |
| BCE | -0.75% | 23.315 | $ | |
| JRI | 0.25% | 13.865 | $ | |
| BP | 0.07% | 35.225 | $ |
Natural immunity more potent than vaccines during US Delta wave: study
During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.
The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).
The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.
Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.
"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.
"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.
The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.
It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.
Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.
- Selection bias? -
By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.
In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.
Protection was highest among those who had both vaccination and prior Covid.
The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.
Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.
But the US CDC had previously taken the opposite position, based on pre-Delta data.
"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.
C.Meier--BTB